Gemigliptin is a dpp-4 inhibitor which is use for type 2 diabetes. DPP-4 inhibitors is to increase incretin levels (GLP-1 and GIP), which inhibit glucagon release, which in turn increases insulin secretion and decreases blood glucose level. Rosuvastatin is a HMG-CoA inhibitor, it reduce the cholesterol level. Fixed dose Combination of Gemigliptin and Rosuvastatin showed significant improvement in HbA1C and LDL-C level in T2DM patient with Dyslipidemia and the therapy was well tolerated.